La Jolla Institute Launches New RNAi Center

The La Jolla Institute for Allergy & Immunology has launched a new center that will focus on using RNAi to study the genetics involved in human diseases and to develop new therapies to combat those maladies.  

The center will undertake four initial lines of research that will leverage La Jolla’s expertise in immunology, focusing on how the body recognizes bacteria and viruses and battles infection. These studies include efforts to understand how the immune system can harm the body, and what genes cause autoimmune diseases such as type 1 diabetes, multiple sclerosis, and rheumatoid arthritis.